|
1
|
Stiller CA: International patterns of
cancer incidence in adolescents. Cancer Treat Rev. 33:631–645.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mankin HJ, Hornicek FJ, Rosenberg AE,
Harmon DC and Gebhardt MC: Survival data for 648 patients with
osteosarcoma treated at one institution. Clin Orthop Relat Res.
429:286–291. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Harting MT, Blakely ML, Jaffe N, et al:
Long-term survival after aggressive resection of pulmonary
metastases among children and adolescents with osteosarcoma. J
Pediatr Surg. 41:194–199. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Merlos-Suárez A, Barriga FM, Jung P, et
al: The intestinal stem cell signature identifies colorectal cancer
stem cells and predicts disease relapse. Cell Stem Cell. 8:511–524.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Takahashi S, Kamiyama T, Tomaru U, et al:
Frequency and pattern of expression of the stem cell marker CD133
have strong prognostic effect on the surgical outcome of colorectal
cancer patients. Oncol Rep. 24:1201–1212. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ailles LE and Weissman IL: Cancer stem
cells in solid tumors. Curr Opin Biotechnol. 18:460–466. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huarte M and Rinn JL: Large non-coding
RNAs: missing links in cancer? Hum Mol Genet. 19:R152–R161. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Spizzo R, Almeida MI, Colombatti A and
Calin GA: Long non-coding RNAs and cancer: a new frontier of
translational research? Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tsai MC, Spitale RC and Chang HY: Long
intergenic noncoding RNAs: new links in cancer progression. Cancer
Res. 71:3–7. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guttman M, Donaghey J, Carey BW, et al:
lincRNAs act in the circuitry controlling pluripotency and
differentiation. Nature. 477:295–300. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Preker P, Nielsen J, Kammler S, et al: RNA
exosome depletion reveals transcription upstream of active human
promoters. Science. 322:1851–1854. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jacquier A: The complex eukaryotic
transcriptome: unexpected pervasive transcription and novel small
RNAs. Nat Rev Genet. 10:833–844. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Preker P, Almvig K, Christensen MS, et al:
PROMoter uPstream Transcripts share characteristics with mRNAs and
are produced upstream of all three major types of mammalian
promoters. Nucleic Acids Res. 39:7179–7193. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Taft RJ, Kaplan CD, Simons C and Mattick
JS: Evolution, biogenesis and function of promoter-associated RNAs.
Cell Cycle. 8:2332–2338. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ijichi N, Ikeda K, Fujita M, et al: EPAS1,
a dexamethasone-inducible gene in osteoblasts, inhibits
osteoblastic differentiation. Open Bone J. 1:28–37. 2009.
View Article : Google Scholar
|
|
16
|
Li Z, Bao S, Wu Q, et al:
Hypoxia-inducible factors regulate tumorigenic capacity of glioma
stem cells. Cancer Cell. 15:501–513. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gordan JD, Bertout JA, Hu CJ, Diehl JA and
Simon MC: HIF-2alpha promotes hypoxic cell proliferation by
enhancing c-myc transcriptional activity. Cancer Cell. 11:335–347.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Covello KL, Kehler J, Yu H, et al:
HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell
function, embryonic development, and tumor growth. Genes Dev.
20:557–570. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang X, Song JH, Cheng YL, et al: Long
non-coding RNA HNF1A-AS1 regulates proliferation and migration in
oesophageal adenocarcinoma cells. Gut. 63:881–890. 2014. View Article : Google Scholar
|
|
20
|
Siclari VA and Qin L: Targeting the
osteosarcoma cancer stem cell. J Orthop Surg Res. 5:782010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tirino V, Desiderio V, d’Aquino R, et al:
Detection and characterization of CD133+ cancer stem
cells in human solid tumours. PLoS One. 3:e34692008. View Article : Google Scholar
|
|
22
|
Williams GT, Mourtada-Maarabouni M and
Farzaneh F: A critical role for non-coding RNA GAS5 in growth
arrest and rapamycin inhibition in human T-lymphocytes. Biochem Soc
Trans. 39:482–486. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Knowles HJ, Schaefer KL, Dirksen U and
Athanasou NA: Hypoxia and hypoglycaemia in Ewing’s sarcoma and
osteosarcoma: regulation and phenotypic effects of
Hypoxia-Inducible Factor. BMC Cancer. 10:3722010. View Article : Google Scholar
|
|
24
|
Acker T, Diez-Juan A, Aragones J, et al:
Genetic evidence for a tumor suppressor role of HIF-2alpha. Cancer
Cell. 8:131–141. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu L and Hales CA: Long-term exposure to
hypoxia inhibits tumor progression of lung cancer in rats and mice.
BMC Cancer. 11:3312011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Biswas S, Charlesworth PJ, Turner GD, et
al: CD31 angiogenesis and combined expression of HIF-1α and HIF-2α
are prognostic in primary clear-cell renal cell carcinoma (CC-RCC),
but HIFα transcriptional products are not: implications for
antiangiogenic trials and HIFα biomarker studies in primary CC-RCC.
Carcinogenesis. 33:1717–1725. 2012. View Article : Google Scholar : PubMed/NCBI
|
